These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 1577600

  • 1. [Anticardiolipin antibodies in cutaneous lupus erythematosus. Incidence and importance as a marker of vascular symptoms].
    Tebbe B, Orfanos CE.
    Hautarzt; 1992 Mar; 43(3):130-3. PubMed ID: 1577600
    [Abstract] [Full Text] [Related]

  • 2. [Cutaneous lupus erythematosus and cardiolipin antibodies. Incidence and clinical significance].
    Kind P, Schuppe HC, Jung KP, Degitz K, Lakomek HJ, Goerz G.
    Hautarzt; 1992 Mar; 43(3):126-9. PubMed ID: 1577599
    [Abstract] [Full Text] [Related]

  • 3. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
    Vera-Recabarren MA, García-Carrasco M, Ramos-Casals M, Herrero C.
    Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
    [Abstract] [Full Text] [Related]

  • 4. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 5. [Lupus erythematosus].
    Goerz G, Lehmann P, Schuppe HC, Lakomek HJ, Kind P.
    Z Hautkr; 1990 Mar; 65(3):226, 229-34. PubMed ID: 2339576
    [Abstract] [Full Text] [Related]

  • 6. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B, Tavori S, Lerner M, Tatarsky I, Lorber M.
    Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
    [Abstract] [Full Text] [Related]

  • 7. Immunoglobulin M predominance in cutaneous lupus erythematosus.
    Kontos AP, Jirsari M, Jacobsen G, Fivenson DP.
    J Cutan Pathol; 2005 May; 32(5):352-5. PubMed ID: 15811120
    [Abstract] [Full Text] [Related]

  • 8. IL-17 in cutaneous lupus erythematosus.
    Tanasescu C, Balanescu E, Balanescu P, Olteanu R, Badea C, Grancea C, Vagu C, Bleotu C, Ardeleanu C, Georgescu A.
    Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
    [Abstract] [Full Text] [Related]

  • 9. Clinical course and prognosis of cutaneous lupus erythematosus.
    Tebbe B.
    Clin Dermatol; 2004 Jun; 22(2):121-4. PubMed ID: 15234012
    [Abstract] [Full Text] [Related]

  • 10. [Lupus erythematosus of the skin. An analysis of 97 patients].
    Tebbe B, Orfanos CE.
    Z Hautkr; 1987 Nov 15; 62(22):1563-72, 1577-8, 1583-4. PubMed ID: 3501642
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results.
    Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN.
    Clin Exp Immunol; 1985 Dec 15; 62(3):738-45. PubMed ID: 4085154
    [Abstract] [Full Text] [Related]

  • 13. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D, Teodorescu MR, Varga J, Teodorescu M.
    J Rheumatol; 1998 Apr 15; 25(4):675-80. PubMed ID: 9558168
    [Abstract] [Full Text] [Related]

  • 14. Species specificity of anti-beta 2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation.
    Arvieux J, Darnige L, Hachulla E, Roussel B, Bensa JC, Colomb MG.
    Thromb Haemost; 1996 May 15; 75(5):725-30. PubMed ID: 8725713
    [Abstract] [Full Text] [Related]

  • 15. Anticardiolipin antibodies and disease activity in systemic lupus erythematosus.
    Santiago MB, Viana V, Bueno C, Yoshinari N, de Oliveira RM, Cossermelli W.
    Rev Hosp Clin Fac Med Sao Paulo; 1990 May 15; 45(4):167-70. PubMed ID: 2135827
    [Abstract] [Full Text] [Related]

  • 16. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S, Isenberg DA.
    Br J Rheumatol; 1998 Oct 15; 37(10):1089-94. PubMed ID: 9825748
    [Abstract] [Full Text] [Related]

  • 17. The use of antibody to C5b-9 in the subclassification of lupus erythematosus.
    Magro CM, Crowson AN, Harrist TJ.
    Br J Dermatol; 1996 May 15; 134(5):855-62. PubMed ID: 8736325
    [Abstract] [Full Text] [Related]

  • 18. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
    Walling HW, Sontheimer RD.
    Am J Clin Dermatol; 2009 May 15; 10(6):365-81. PubMed ID: 19824738
    [Abstract] [Full Text] [Related]

  • 19. Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients.
    Tebbe B, Mansmann U, Wollina U, Auer-Grumbach P, Licht-Mbalyohere A, Arensmeier M, Orfanos CE.
    Acta Derm Venereol; 1997 Jul 15; 77(4):305-8. PubMed ID: 9228225
    [Abstract] [Full Text] [Related]

  • 20. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
    Ishikawa O, Zaw KK, Miyachi Y, Hashimoto T, Tanaka T.
    Br J Dermatol; 1997 Feb 15; 136(2):222-6. PubMed ID: 9068736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.